Filter Results
:
(225)
Show Results For
-
All HBS Web
(225)
- News (72)
- Research (127)
- Events (1)
- Multimedia (3)
- Faculty Publications (84)
Show Results For
-
All HBS Web
(225)
- News (72)
- Research (127)
- Events (1)
- Multimedia (3)
- Faculty Publications (84)
- 11 Nov 2014
- First Look
First Look: November 11
organizations, Kaplan and Haas identify five common mistakes when managers attempt to cut health care costs. The mistakes are triggered, primarily, by working from the line-item expense categories on P&Ls, rather than clinically based...
View Details
Keywords:
Sean Silverthorne
- 08 Aug 2017
- First Look
First Look at Research and Ideas, August 8, 2017
reality technology to treat amblyopia (more commonly called “lazy eye”), the single biggest cause of visual disorders among children. By February 2017, the three founders had raised $950,000 in angel funding and developed a prototype of their virtual reality product,...
View Details
Keywords:
Sean Silverthorne
- 04 Oct 2011
- First Look
First Look: October 4
relationship using data from 93 change projects conducted by clinical managers at the National Health Service in the United Kingdom. The results show social position, both within the field and within the organization, influences actors'...
View Details
Keywords:
Sean Silverthorne
- 20 Sep 2011
- First Look
First Look: September 20
surprised to hear as he nurtured the intraoperative radiotherapy business inside his company's microsurgery unit. But he also didn't expect it to take 13 years to get to the end of an all-important clinical View Details
Keywords:
Sean Silverthorne
- 18 Dec 2012
- First Look
First Look: December 18
Cialis's hard-won brand equity with physicians and patients? With the final stages of clinical trials for the new indication, benign prostatic hyperplasia (BPH), soon to be carried out, the team had to make...
View Details
Keywords:
Carmen Nobel
- 21 Feb 2017
- First Look
First Look at New Research: February 21
impacting the mainstream scientific community. Could this NGO model of funding the “right” clinical trials be successful? Could it be duplicated across other scientific areas? What can be learned from NuSI’s...
View Details
Keywords:
Carmen Nobel
- 27 Mar 2012
- First Look
First Look: March 27
years, PAREXEL has built a strong technology services business that is its key differentiator, although clinical trials remain its most lucrative segment. Additionally, PAREXEL, like others in the industry,...
View Details
Keywords:
Carmen Nobel
- 01 Jun 2017
- News
Life in Lockdown
a kitten dangling from a tree limb. One visit to Google kills that idea; there are already dozens of companies catering to premenstrual women. What about a service that can make a visit to an urgent care clinic more efficient and draw...
View Details
- 21 Apr 2009
- First Look
First Look: April 21, 2009
have assumed greater roles in defining disease categories than in the past and now influence clinical trials and participate in regulatory decision making. Yet these developments are far from universal and...
View Details
Keywords:
Martha Lagace
- Web
Podcast - Managing the Future of Work
already knew how to do it.Kerr: Now, do you have any stories that tell us about some of the vaccine development?Wallach: We don’t take credit for the vaccines happening so quickly. But if you want to run trials faster, you better get rid...
View Details
- 01 Nov 2016
- First Look
First Look - November 1, 2016
seeks to complete its clinical trials with very little startup funding and a small staff when compared to its competitors. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/315045-PDF-ENG Harvard...
View Details
Keywords:
Sean Silverthorne
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
cause of blindness. In October 2009 the company entered into licensing and purchase option agreements with Alcon, which is now taking Potentia's drug candidate through Clinical 2 trials with a to-market goal...
View Details
- 01 Jun 2011
- News
The Best-Laid Plans
in on a treatment for age-related macular degeneration, a leading cause of blindness. In October 2009 the company entered into licensing and purchase option agreements with Alcon, which is now taking Potentia’s drug candidate through View Details
- 28 Apr 2009
- First Look
First Look: April 28, 2009
in the past and now influence clinical trials and participate in regulatory decision-making. Yet these developments are far from universal and are taking very different forms around the world. Building on...
View Details
Keywords:
Martha Lagace
- 04 Feb 2014
- First Look
First Look: February 4
that investors were increasingly supporting late stage research with higher probabilities of success, while funding for riskier early stage research was drying up. Should FasterCures raise money and direct it toward early stage breakthrough therapies? Another issue was...
View Details
Keywords:
Sean Silverthlorne
- 01 Oct 1996
- News
Lasting Impressions
"Harvard 'B' for Peace." It was an extraordinary introduction to student life at the B-School, and as events such as the student killings at Kent State and Jackson State, the U.S. invasion of Cambodia, and the trial of the Chicago Seven...
View Details
Keywords:
Deborah E. Blagg
- Web
Print View - Course Catalog
life created, and new custom designed materials could be grown rather than manufactured. Companies like Verve Therapeutics announced the first human trials of a single shot cure for all heart attacks through a one-time change in a single...
View Details